Biologic activity of MCNU: a new antitumor agent
- PMID: 466655
Biologic activity of MCNU: a new antitumor agent
Abstract
A novel nitrosourea derivative, methyl-6-[[[(2-chloroethyl)nitrosoamino]carbonyl]-amino]-6-deoxy-alpha-D-glucopyranoside (MCNU), is a water-soluble compound in which a methoxyl group is attached to the C-1 position and an N-(2-chloroethyl)-N-nitrosoureido group is attached to the C-6 position of the glucose moiety. MCNU exhibited a marked life-prolongation or growth-inhibitory effect against mouse L1210 leukemia, adenocarcinoma 755, Nakahara-Fukuoka sarcoma, Lewis lung carcinoma, and B16 melanoma. Ip, oral, or iv administration of MCNU was markedly effective against L1210 leukemia, and the therapeutic ratio by ip administration was larger than that of chlorozotocin or CCNU. The life-prolongation effect of MCNU against established Lewis lung carcinoma was similar to that of methyl-CCNU. The bone marrow toxicity of MCNU was less than that of CCNU but considerably more than that of chlorozotocin.
Similar articles
-
Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.Gan. 1984 Oct;75(10):937-46. Gan. 1984. PMID: 6510639
-
[Experimental studies on oral administration of nitrosourea anti-tumor agent, MCNU].Gan To Kagaku Ryoho. 1984 Jul;11(7):1492-500. Gan To Kagaku Ryoho. 1984. PMID: 6234861 Japanese.
-
Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.Cancer Res. 1985 Feb;45(2):695-702. Cancer Res. 1985. PMID: 3881170
-
Nitrosoureas: a review of experimental antitumor activity.Cancer Treat Rep. 1976 Jun;60(6):665-98. Cancer Treat Rep. 1976. PMID: 782694 Review.
-
1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review.Adv Cancer Res. 1972;16:273-332. doi: 10.1016/s0065-230x(08)60343-7. Adv Cancer Res. 1972. PMID: 4563045 Review. No abstract available.
Cited by
-
A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity.Cancer Chemother Pharmacol. 1982;9(3):134-9. doi: 10.1007/BF00257741. Cancer Chemother Pharmacol. 1982. PMID: 6218931
-
Linkage between O6-methylguanine-DNA methyltransferase (O6-MT) activity and cellular resistance to antitumour nitrosoureas in cultured rat brain tumour cell strains.Acta Neurochir (Wien). 1990;103(1-2):62-6. doi: 10.1007/BF01420193. Acta Neurochir (Wien). 1990. PMID: 2360469
-
Enhanced antitumor activity and reduced toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea administered in lipid microspheres to tumor-bearing mice.Jpn J Cancer Res. 1993 Oct;84(10):1078-85. doi: 10.1111/j.1349-7006.1993.tb02804.x. Jpn J Cancer Res. 1993. PMID: 8226282 Free PMC article.
-
MCNU in the treatment of essential thrombocythemia--a pilot study.Ann Hematol. 1993 May;66(5):247-9. doi: 10.1007/BF01738474. Ann Hematol. 1993. PMID: 8507720
-
Characterization of the anti-tumour activity against solid tumours of a new nitrosoureido sugar: Cy 233.Cancer Chemother Pharmacol. 1989;25(3):205-9. doi: 10.1007/BF00689584. Cancer Chemother Pharmacol. 1989. PMID: 2598412